Methotrexate therapy in polymyositis.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001706:Biopsy; D003402:Creatine Kinase / Q000097:blood; D003882:Dermatomyositis / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008168:Lung / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy* / Q000201:enzymology; D009220:Myositis / Q000150:complications / Q000188:drug therapy; D011014:Pneumonia / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D011859:Radiography; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase; D011241:Prednisone; D008727:Methotrexate